- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00513448
Promoting Physical Activity for Persons With Multiple Sclerosis
August 7, 2007 updated by: University of Minnesota
Comparing Individualized Rehabilitation to a Group Wellness Intervention for Persons With Multiple Sclerosis
The purpose of this study was to determine whether a group wellness intervention or individualized physical rehabilitation was more effective in improving health and physical activity in persons with multiple sclerosis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Evidence from this study shows that both interventions were effective in improving health and physical activity in persons with multiple sclerosis.
The results also show that participants may benefit more physically from individualized physical rehabilitation and more mentally from group wellness interventions.
Interventions that combine individualized therapeutic exercise with group health education might be most effective for persons with multiple sclerosis.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- A physician-confirmed diagnosis of MS
- Between the ages of 18 to 75 years
- Ability to ambulate 25 meters with or without the use of an adaptive aide
Exclusion Criteria:
- Pregnant
- Cardiovascular disease
- Had fallen more than twice in the past month
- Significant cognitive deficits
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Modified Fatigue Impact Scale SF-36 Mental Health Inventory
Time Frame: 16 weeks
|
16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Physical assessments
Time Frame: 16-weeks
|
16-weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Matthew A Plow, PhD, Brown University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2005
Study Completion (Actual)
November 1, 2005
Study Registration Dates
First Submitted
August 7, 2007
First Submitted That Met QC Criteria
August 7, 2007
First Posted (Estimate)
August 8, 2007
Study Record Updates
Last Update Posted (Estimate)
August 8, 2007
Last Update Submitted That Met QC Criteria
August 7, 2007
Last Verified
August 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0311M53442
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Group wellness intervention
-
Kessler FoundationUniversity of California, San Diego; University of Michigan; Rehabilitation Hospital... and other collaboratorsRecruitingDementia | Traumatic Brain Injury | Alzheimer's Disease | Mild Traumatic Brain Injury | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateUnited States
-
The University of Texas Health Science Center at...National Cancer Institute (NCI); Wake Forest University Health Sciences; Arizona... and other collaboratorsRecruitingDepression | Inflammation | Cancer | Fatigue | Anxiety | Sleep DisturbanceUnited States
-
Virginia Commonwealth UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPediatric ObesityUnited States
-
Saglik Bilimleri UniversitesiNot yet recruiting
-
University of MiamiTerminatedMelanomaUnited States
-
University of Nevada, RenoActive, not recruitingAnxiety | Depression Not Otherwise Specified | Burnout, Healthcare Workers | Wellness ProgramUnited States
-
Virginia Commonwealth UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedOverweight and ObesityUnited States
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Palo Alto Veterans Institute for ResearchUnited States Department of DefenseCompletedChronic Pain | Gulf War Illness | Chronic IllnessUnited States
-
VA Office of Research and DevelopmentBoston University; Tufts Medical CenterCompleted